Found: 22
Select item for more details and to access through your institution.
Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 2, p. 619, doi. 10.1007/s00432-020-03365-w
- By:
- Publication type:
- Article
Symptom burden and health-related quality of life impacts of smoldering multiple myeloma: the patient perspective.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41687-020-00253-2
- By:
- Publication type:
- Article
Using a digital patient powered research network to identify outcomes of importance to patients with multiple myeloma.
- Published in:
- Journal of Patient-Reported Outcomes, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1186/s41687-020-00242-5
- By:
- Publication type:
- Article
Literature review to assemble the evidence for response scales used in patient-reported outcome measures.
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0056-3
- By:
- Publication type:
- Article
Response scale selection in adult pain measures: results from a literature review.
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0053-6
- By:
- Publication type:
- Article
Literature review to characterize the empirical basis for response scale selection in pediatric populations.
- Published in:
- Journal of Patient-Reported Outcomes, 2018, v. 2, n. 1, p. N.PAG, doi. 10.1186/s41687-018-0051-8
- By:
- Publication type:
- Article
Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives.
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 3, p. 375, doi. 10.1007/s40258-016-0282-x
- By:
- Publication type:
- Article
Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 3, p. 231, doi. 10.1007/s40258-014-0093-x
- By:
- Publication type:
- Article
The patient experience of relapsed refractory multiple myeloma and perspectives on emerging therapies.
- Published in:
- Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1603
- By:
- Publication type:
- Article
Health‐related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 132, doi. 10.1111/bjh.17435
- By:
- Publication type:
- Article
Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 561, doi. 10.1111/bjh.17321
- By:
- Publication type:
- Article
Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 5, p. 1172, doi. 10.1177/10781552221103551
- By:
- Publication type:
- Article
Health‐related quality of life in transplant‐eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone: Patient‐reported outcomes from GRIFFIN.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1257, doi. 10.1002/ajh.27326
- By:
- Publication type:
- Article
Health‐related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient‐reported outcomes from the APOLLO trial.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. 481, doi. 10.1002/ajh.26480
- By:
- Publication type:
- Article
Subcutaneous daratumumab in Asian patients with heavily pretreated multiple myeloma: subgroup analyses of the noninferiority, phase 3 COLUMBA study.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 4, p. 1065, doi. 10.1007/s00277-021-04405-2
- By:
- Publication type:
- Article
Patient Perceptions Regarding Multiple Myeloma and Its Treatment: Qualitative Evidence from Interviews with Patients in the United Kingdom, France, and Germany.
- Published in:
- Patient, 2021, v. 14, n. 5, p. 613, doi. 10.1007/s40271-021-00501-7
- By:
- Publication type:
- Article
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Greater Treatment Satisfaction in Patients Receiving Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) for Relapsed or Refractory Multiple Myeloma (RRMM): COLUMBA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e247, doi. 10.1016/j.clml.2019.09.410
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e225, doi. 10.1016/j.clml.2019.09.375
- By:
- Publication type:
- Article
MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2017, v. 26, n. 12, p. 1483, doi. 10.1002/pds.4255
- By:
- Publication type:
- Article
Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Psychometric evaluation of the National Eye Institute Visual Function Questionnaire and Visual Function Questionnaire Utility Index in patients with non-infectious intermediate and posterior uveitis.
- Published in:
- Quality of Life Research, 2013, v. 22, n. 10, p. 2801, doi. 10.1007/s11136-013-0412-y
- By:
- Publication type:
- Article